Cardiac Autonomic Neuropathy
Cardiac autonomic neuropathy risk estimated by sudomotor function and arterial stiffness in Chinese subjects
Zeng Q, Dong SY, Wang ML, Wang F, Li JM, Zhao XL.
October 11, 2016
No Comments
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12
